NL7308482A - - Google Patents

Info

Publication number
NL7308482A
NL7308482A NL7308482A NL7308482A NL7308482A NL 7308482 A NL7308482 A NL 7308482A NL 7308482 A NL7308482 A NL 7308482A NL 7308482 A NL7308482 A NL 7308482A NL 7308482 A NL7308482 A NL 7308482A
Authority
NL
Netherlands
Application number
NL7308482A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308482A publication Critical patent/NL7308482A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7308482A 1972-06-19 1973-06-19 NL7308482A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2229770A DE2229770A1 (de) 1972-06-19 1972-06-19 N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NL7308482A true NL7308482A (en:Method) 1973-12-21

Family

ID=5848095

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308482A NL7308482A (en:Method) 1972-06-19 1973-06-19

Country Status (14)

Country Link
US (1) US3931187A (en:Method)
JP (1) JPS5732073B2 (en:Method)
AT (6) AT328626B (en:Method)
BE (1) BE801083A (en:Method)
CH (6) CH597234A5 (en:Method)
DE (1) DE2229770A1 (en:Method)
DK (1) DK140408C (en:Method)
ES (5) ES416038A1 (en:Method)
FI (1) FI56180C (en:Method)
FR (1) FR2189054B1 (en:Method)
GB (1) GB1430958A (en:Method)
NL (1) NL7308482A (en:Method)
NO (1) NO137998C (en:Method)
SE (1) SE409035B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62298530A (ja) * 1986-06-16 1987-12-25 Otsuka Pharmaceut Co Ltd 坐薬用医薬組成物
ES2297882T3 (es) * 1997-03-27 2008-05-01 Toray Industries, Inc. Derivados de morfinano y usos medicos de los mismos.
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行n-脫烷反應之方法
TWI478928B (zh) 2010-06-11 2015-04-01 Rhodes Technologies 用於製備n-烯丙基化合物之過渡金屬催化的製程及其用途
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB1223445A (en) * 1968-07-18 1971-02-24 Reckitt & Colmann Prod Ltd Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation
US3562279A (en) * 1969-05-15 1971-02-09 American Cyanamid Co Substituted 7,8-dihydro - 6 - methoxy-6,14-endo(etheno or ethano)morphide - 7-ketones and n-cycloalkylmethyl - 7,8-dihydro - 6 - methoxy-6,14-endo(etheno or ethano) norcodide-7-ketones
US3560505A (en) * 1969-05-15 1971-02-02 American Cyanamid Co Substituted 7-(1-alkoxy - 1 - alken-1-yl)-7,8-dihydro-6-methoxy-6,14-endo- (etheno or ethano) codides and morphides
DE2107989A1 (de) * 1971-02-19 1972-09-07 Boehringer Sohn Ingelheim N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
DE2229770A1 (de) 1974-01-10
NO137998C (no) 1978-06-07
DK140408C (da) 1980-01-21
US3931187A (en) 1976-01-06
ES424307A1 (es) 1976-07-01
CH599214A5 (en:Method) 1978-05-12
ATA265974A (de) 1975-05-15
AU5704773A (en) 1974-12-19
AT325217B (de) 1975-10-10
ATA265874A (de) 1975-05-15
CH597234A5 (en:Method) 1978-03-31
ES424309A1 (es) 1976-06-16
ES416038A1 (es) 1976-06-16
FR2189054B1 (en:Method) 1976-12-31
CH596212A5 (en:Method) 1978-03-15
FI56180B (fi) 1979-08-31
BE801083A (fr) 1973-12-18
FI56180C (fi) 1979-12-10
ATA265674A (de) 1975-05-15
AT328097B (de) 1976-03-10
AT328626B (de) 1976-03-25
ATA265774A (de) 1975-06-15
AT328625B (de) 1976-03-25
AT328095B (de) 1976-03-10
NO137998B (no) 1978-02-27
JPS5732073B2 (en:Method) 1982-07-08
FR2189054A1 (en:Method) 1974-01-25
DK140408B (da) 1979-08-20
AT328096B (de) 1976-03-10
SE409035B (sv) 1979-07-23
GB1430958A (en) 1976-04-07
ES424308A1 (es) 1976-06-16
CH599215A5 (en:Method) 1978-05-12
CH598260A5 (en:Method) 1978-04-28
JPS4961188A (en:Method) 1974-06-13
CH597233A5 (en:Method) 1978-03-31
ES424310A1 (es) 1976-06-16

Similar Documents

Publication Publication Date Title
JPS4972095A (en:Method)
USB214925I5 (en:Method)
FR2211725B1 (en:Method)
FR2189054B1 (en:Method)
CS157360B1 (en:Method)
CS160328B1 (en:Method)
FR2202026B1 (en:Method)
JPS5135318B2 (en:Method)
JPS5028U (en:Method)
JPS4923262A (en:Method)
JPS4994793A (en:Method)
JPS5223792Y2 (en:Method)
JPS5136625B2 (en:Method)
CS159143B1 (en:Method)
CS159832B1 (en:Method)
CS153907B1 (en:Method)
JPS4953684U (en:Method)
CS153928B1 (en:Method)
JPS49102894U (en:Method)
JPS48111053U (en:Method)
CS153938B1 (en:Method)
CS154076B1 (en:Method)
CS160344B1 (en:Method)
CS155492B1 (en:Method)
CS156835B1 (en:Method)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed